注册号: Registration number: |
ChiCTR1900026632 |
最近更新日期: Date of Last Refreshed on: |
2019-10-16 |
注册时间: Date of Registration: |
2019-10-16 |
注册号状态: |
预注册 |
Registration Status: |
Prospective registration |
注册题目: |
中国 ICU 内成人非肝病性高血氨的横断面研究 |
Public title: |
Cross-sectional study of non-hepatic hyperammonemia in ICU of Chineses |
注册题目简写: |
|
English Acronym: |
|
研究课题的正式科学名称: |
中国 ICU 内成人非肝病性高血氨的横断面研究 |
Scientific title: |
Cross-sectional study of non-hepatic hyperammonemia in ICU of Chineses |
研究课题代号(代码): Study subject ID: |
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
申请注册联系人: |
姚志鹏 |
研究负责人: |
王洪亮 |
Applicant: |
Yao Zhipeng |
Study leader: |
Wang Hongliang |
申请注册联系人电话: Applicant telephone: |
+86 13895792689 |
研究负责人电话: Study leader's telephone: |
+86 15045377888 |
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
申请注册联系人电子邮件: Applicant E-mail: |
yaozhipeng215@163.com |
研究负责人电子邮件: Study leader's E-mail: |
icuwanghongliang@163.com |
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
申请注册联系人通讯地址: |
黑龙江省哈尔滨市南岗区学府路 246 号 |
研究负责人通讯地址: |
黑龙江省哈尔滨市南岗区学府路 246 号 |
Applicant address: |
246 Xuefu Road, Nangang District, Harbin, Heilongjiang, China |
Study leader's address: |
246 Xuefu Road, Nangang District, Harbin, Heilongjiang, China |
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
申请人所在单位: |
哈尔滨医科大学附属第二医院 |
||
Applicant's institution: |
The Second Affiliated Hospital of Harbin Medical University |
是否获伦理委员会批准: |
是 |
||
Approved by ethic committee: |
Yes |
||
伦理委员会批件文号: Approved No. of ethic committee: |
KY2019-184 |
伦理委员会批件附件: Approved file of Ethical Committee: |
|
批准本研究的伦理委员会名称: |
哈尔滨医科大学附属第二医院 |
||
Name of the ethic committee: |
The Second Affiliated Hospital of Harbin Medical University |
||
伦理委员会批准日期: Date of approved by ethic committee: |
2019-05-23 | ||
伦理委员会联系人: |
郝天军 |
||
Contact Name of the ethic committee: |
Hao Tianjun |
||
伦理委员会联系地址: |
黑龙江省哈尔滨市南岗区学府路 246 号 |
||
Contact Address of the ethic committee: |
246 Xuefu Road, Nangang District, Harbin, Heilongjiang, China |
||
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
研究实施负责(组长)单位: |
哈尔滨医科大学附属第二医院 |
||||||||||||||||||||||
Primary sponsor: |
The Second Affiliated Hospital of Harbin Medical University |
||||||||||||||||||||||
研究实施负责(组长)单位地址: |
黑龙江省哈尔滨市南岗区学府路 246 号 |
||||||||||||||||||||||
Primary sponsor's address: |
246 Xuefu Road, Nangang District, Harbin, Heilongjiang, China |
||||||||||||||||||||||
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
经费或物资来源: |
自筹 |
||||||||||||||||||||||
Source(s) of funding: |
raise independently |
||||||||||||||||||||||
研究疾病: |
非肝病性高血氨 |
||||||||||||||||||||||
Target disease: |
non-hepatic hyperammonemia |
||||||||||||||||||||||
研究疾病代码: |
|
||||||||||||||||||||||
Target disease code: |
|
||||||||||||||||||||||
研究类型: |
流行病学研究 |
||||||||||||||||||||||
Study type: |
Epidemilogical research |
||||||||||||||||||||||
研究所处阶段: |
其它 | ||||||||||||||||||||||
Study phase: |
N/A |
||||||||||||||||||||||
研究目的: |
中国ICU内成人非肝病性高血氨的发生率以及临床特点 |
||||||||||||||||||||||
Objectives of Study: |
ncidence and clinical characteristics of non-hepatic hyperammonemia in ICU of Chinese |
||||||||||||||||||||||
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
研究设计: |
连续入组 |
||||||||||||||||||||||
Study design: |
Sequential |
||||||||||||||||||||||
纳入标准: |
(1) 研究期间转入和直接入住ICU的患者; (2) 年龄≥18周岁; (3) 调查期间符合入选标准的全部患者。 |
||||||||||||||||||||||
Inclusion criteria |
(1) patients transferred to and directly admitted to ICU during the study period; (2) Aged >=18 years old; (3) all patients meeting the inclusion criteria during the survey period. |
||||||||||||||||||||||
排除标准: |
(1)急性肝衰竭; (2)慢性肝病; (3)再次入住ICU; (4)未签署知情同意的患者。 |
||||||||||||||||||||||
Exclusion criteria: |
(1) acute liver failure; (2) chronic liver disease; (3) re-admission to ICU; (4) patients without informed consent. |
||||||||||||||||||||||
研究实施时间: Study execute time: |
从From2019-11-01至To 2020-06-30 |
干预措施: Interventions: |
|
研究实施地点: Countries of recruitment and research settings: |
|
测量指标: Outcomes: |
|